Personnel

Joseph F. O'Neill, MD, named CEO of immune therapies company

Published in AIDS Weekly, November 28th, 2005

The Immune Response Corporation (IMNR) announced the appointment of Joseph F. O'Neill, MD, MPH, as its new chief executive officer and president, succeeding John N. Bonfiglio, PhD.

O'Neill comes to The Immune Response Corporation after a career leading federal AIDS policy at the White House, the Office of the U.S. Secretary of Health and Human Services, and the office of the global AIDS coordinator at the U.S. Department of State.

O'Neill was chief architect of the president's 2003 Emergency Plan for AIDS Relief, known as PEPFAR, a $15 billion U.S. government-led global initiative to combat the HIV/AIDS epidemic. He will use his experience and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2005-11-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry